| S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects | Science advances |  | | 2024 | 352 | 188 |
|
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease | | | 2023 | 328 | 234 |
|
| Hepatic non-parenchymal S100A9-TLR4-mTORC1 axis normalizes diabetic ketogenesis | Nature communications | | | 2022 | 387 | 133 |
|
| Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells | Communications Biology | | | 2021 | 349 | 232 |
|
